Glenmark Pharmaceuticals Limited — Board Meeting, 14-08-2025: Outcome of Board Meeting

Glenmark Pharma's board has approved transferring its Consumer Care business to a new wholly-owned subsidiary, Glenmark Consumer Care Ltd. This strategic move, involving assets valued around INR 240.40 Cr, aims for sharper focus and value creation in the growing consumer care sector. The business generated INR 514.7 Cr turnover and INR 249.2 Cr net worth last fiscal year. Also, Ms. Patricia Andrews joins as an Independent Director, and new Statutory and Secretarial Auditors were appointed. The 47th Annual General Meeting is set for September 26, 2025.